Literature DB >> 9572394

Characterization of a hormone response element in the mouse N-acetyltransferase 2 (Nat2*) promoter.

L Estrada-Rodgers1, G N Levy, W W Weber.   

Abstract

Multiple variant alleles of the human arylamine N-acetyltransferase genes, NAT1* and NAT2*, alter the capacity of individuals to metabolize arylamines by N-acetylation. Although biochemical and genetic studies have improved our understanding of the molecular basis of the acetylation polymorphism in humans and other mammals, regulation of NAT* gene expression is not understood. In the present study, a segment of the 5'-untranslated region of mouse Nat2* was sequenced and characterized. Primer extension analysis and RNase protection assays exposed multiple transcription initiation sites located 112 to 151 bases upstream of the translational start site. Computer sequence analysis revealed a promoter-like region located within the region 530 bases upstream of the translational start site consisting of TATA boxes, upstream promoter elements such as a CAAT box and Sp1 binding site, regulatory elements such as a palindromic hormone response element (HRE), and enhancer regions such as an AP-1 transcription factor binding site. Transient expression of CAT reporter constructs of the mouse Nat2*-palindromic HRE demonstrated positive regulation of the HSV-thymidine kinase 1 (tk1) promoter and induced the expression of chloramphenicol acetyltransferase (CAT). This induction was initiated by the addition of hormones such as 5alpha-dihydrotestosterone (DHT) or dexamethasone and was entirely dependent on the presence of androgen or glucocorticoid receptors, respectively. Together with recent discoveries regarding the effects of testosterone on the expression of Nat2* in mouse kidney during development, the findings reported in this article suggest that the HRE found in the promoter region of Nat2* is a potential candidate for the mediation of androgenic regulation of Nat2* in mouse kidney.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9572394      PMCID: PMC6151942     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  26 in total

1.  Molecular and genetic analyses of arylamine N-acetyltransferase polymorphism of rabbit liver.

Authors:  Y Sasaki; S Ohsako; T Deguchi
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

2.  In vivo mechanisms for the enhanced acetylation of sulfamethazine in the rabbit after hydrocortisone treatment.

Authors:  P T Reeves; R F Minchin; K F Ilett
Journal:  J Pharmacol Exp Ther       Date:  1989-01       Impact factor: 4.030

3.  Cloning, sequencing and expression of NAT1 and NAT2 encoding genes from rapid and slow acetylator inbred rats.

Authors:  M A Doll; D W Hein
Journal:  Pharmacogenetics       Date:  1995-08

4.  Promoter and transcription start site of human and rabbit butyrylcholinesterase genes.

Authors:  O Jbilo; J P Toutant; K P Vatsis; A Chatonnet; O Lockridge
Journal:  J Biol Chem       Date:  1994-08-19       Impact factor: 5.157

5.  N-acetylation pharmacogenetics: a gene deletion causes absence of arylamine N-acetyltransferase in liver of slow acetylator rabbits.

Authors:  M Blum; D M Grant; A Demierre; U A Meyer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

6.  Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus.

Authors:  K P Vatsis; W W Weber
Journal:  Arch Biochem Biophys       Date:  1993-02-15       Impact factor: 4.013

7.  Testosterone modulation of N-acetylation in mouse kidney.

Authors:  T N Smolen; J A Brewer; W W Weber
Journal:  J Pharmacol Exp Ther       Date:  1993-02       Impact factor: 4.030

8.  Multiple components of a complex androgen-dependent enhancer.

Authors:  A J Adler; A Scheller; Y Hoffman; D M Robins
Journal:  Mol Endocrinol       Date:  1991-11

9.  Testosterone increases N-acetyltransferase activity in both male and female Syrian hamster harderian glands.

Authors:  A Menendez-Pelaez; B Marrufo; R J Reiter; C Santana; J M Guerrero
Journal:  Biochem Int       Date:  1989-07

10.  Polymorphic arylamine N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic Syrian hamsters.

Authors:  R J Ferguson; M A Doll; B R Baumstark; D W Hein
Journal:  Gene       Date:  1994-03-25       Impact factor: 3.688

View more
  9 in total

1.  Glucocorticoid receptor-mediated transcriptional regulation of N-acetyltransferase 1 gene through distal promoter.

Authors:  Barbara Bonamassa; Yongjie Ma; Dexi Liu
Journal:  AAPS J       Date:  2012-05-30       Impact factor: 4.009

2.  Functional properties of an alternative, tissue-specific promoter for human arylamine N-acetyltransferase 1.

Authors:  David F Barker; Anwar Husain; Jason R Neale; Benjamin D Martini; Xiaoyan Zhang; Mark A Doll; J Christopher States; David W Hein
Journal:  Pharmacogenet Genomics       Date:  2006-07       Impact factor: 2.089

3.  Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population.

Authors:  Veerapol Kukongviriyapan; Auemduan Prawan; Benjamart Warasiha; Wichittra Tassaneyakul; Jareerat Aiemsa-ard
Journal:  Eur J Clin Pharmacol       Date:  2003-07-19       Impact factor: 2.953

4.  Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1).

Authors:  Neville J Butcher; Ajanthy Arulpragasam; Catherine Pope; Rodney F Minchin
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

5.  Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice.

Authors:  Sotiria Boukouvala; Naomi Price; Kathryn E Plant; Edith Sim
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

6.  Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer.

Authors:  Hideo Suzuki; Jeffrey S Morris; Yanan Li; Mark A Doll; David W Hein; Jun Liu; Li Jiao; Manal M Hassan; Rena S Day; Melissa L Bondy; James L Abbruzzese; Donghui Li
Journal:  Carcinogenesis       Date:  2008-05-21       Impact factor: 4.944

Review 7.  Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.

Authors:  E Sim; A Abuhammad; A Ryan
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

8.  Spermidine/spermine N1-acetyltransferase-1 as a diagnostic biomarker in human cancer.

Authors:  Andrew W Maksymiuk; Daniel S Sitar; Rashid Ahmed; Brian Cheng; Horacio Bach; Rushita Adhikari Bagchi; Nina Aroutiounova; Paramjit S Tappia; Bram Ramjiawan
Journal:  Future Sci OA       Date:  2018-09-10

Review 9.  Melatonin Synthesis and Function: Evolutionary History in Animals and Plants.

Authors:  Dake Zhao; Yang Yu; Yong Shen; Qin Liu; Zhiwei Zhao; Ramaswamy Sharma; Russel J Reiter
Journal:  Front Endocrinol (Lausanne)       Date:  2019-04-17       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.